TrialDer Urologe. Ausg. A2022

[Combining avelumab and stereotactic ablative body radiotherapy in metastatic castration-resistant prostate cancer : Efficacy and safety-phase II ICE-PAC].

Ulrich Alexander KrafftPubMed ↗Publisher ↗

No numbers read from the abstract.